Stock Rating Downgrade In recent days the Value Trend Rating for Imperial Oil Ltd (NYSEAMERICAN: IMO) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Imperial Oil Ltd (NYSEAMERICAN: […]
Stock Rating Upgrade During the last several trading days the Value Trend Rating for BK Technologies Corp (NYSEAMERICAN: BKTI) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action BK […]
Stock Rating Upgrade The Value Trend Rating for Acme United Corp (NYSEAMERICAN: ACU) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]
Evi Industries Inc (NYSEAMERICAN: EVI) stock closed at $18.56 on 3/20/25 after a major decline of -10.6%. Moreover, exceptionally high trading volume at 383% of normal accompanied the decline. The stock has performed in line […]
Idaho Strategic Resources Inc (NYSEAMERICAN: IDR). Extremely significant positive changes in investment behavior have recently occurred: positive upside/downside volume developed, the stock’s recent price rise disrupted its longer term downtrend, and the stock rose on […]
Stock Rating Downgrade In the last week the Value Trend Rating for Acme United Corp (NYSEAMERICAN: ACU) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 3/14/25, Acme […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Uranium Energy Corp (NYSEAMERICAN: UEC) weakened in recent days. UEC’s current Value Trend Rating is D and the prior Rating […]
BK Technologies Corp (NYSEAMERICAN: BKTI) stock closed at $30.29 on 3/11/25 after a major increase of 12.2%. This advance was accompanied by normal trading volume. The stock has risen 8.1% during the last week and […]
Cryo-Cell International Inc (NYSEAMERICAN: CCEL) suffers from extremely meaningful negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent significant negative changes in fundamentals have impacted Cryo-Cell […]
inTest Corp (NYSEAMERICAN: INTT) has reported E.P.S. of $0.12 for its fourth fiscal quarter (ending December 31) versus $0.12 for the same period a year ago — flat performance. Relative to the consensus estimate of […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research